Ligand validation:2YLX

MES: 2-(N-MORPHOLINO)-ETHANESULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YLX_MES_A_702	8%	7%	0.467	0.948	2.32	2.71	1	6	2	0	100%	0.5
2YLT_MES_A_1543	82%	6%	0.129	0.984	2.17	3.11	1	9	4	0	100%	1
2YLW_MES_A_702	75%	7%	0.143	0.977	2.02	2.96	1	7	2	0	100%	1
8AJQ_MES_H_201	100%	39%	0.037	0.992	1.52	0.93	1	1	0	0	100%	1
4NWT_MES_L_301	100%	25%	0.045	0.99	1.24	1.94	2	4	0	0	100%	1
4S23_MES_B_502	100%	24%	0.05	0.993	1.97	1.34	1	1	0	0	100%	1
5NJ9_MES_A_502	99%	61%	0.049	0.988	0.71	0.74	-	1	0	0	100%	1
4BRG_MES_B_1399	99%	13%	0.061	0.988	1.72	2.42	3	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.